• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELSOFT PLUS; GELSOFT PLUS BIFURCATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELSOFT PLUS; GELSOFT PLUS BIFURCATE Back to Search Results
Model Number GELSOFT PLUS BIFURCATE
Device Problem Material Integrity Problem (2978)
Patient Problem Aneurysm (1708)
Event Date 01/05/2024
Event Type  Injury  
Manufacturer Narrative
Manufacturers narrative: health effect: 1708 - aneurysm: on (b)(6) 2023, blood leakage was observed from the bifurcation of the graft, causing the aneurysm to enlarge.Impact code: 4625 - additional surgery was performed.4624 - surgical intervention - further surgery was needed to remove device.4627 - device explanation - device was implanted on (b)(6) 2011, device was explanted on (b)(6) 2024 and is being returned for investigation.4642 - additional device was required - a vascular graft was implanted on (b)(6) 2024.Medical device problem code: 2978 - material integrity problem - bifurcate was explanted and a hole was found at the bifurcation of the graft.Component code: 4755 - part / component/ sub-assembly code not applicable - this device has no component parts.
 
Event Description
The patient underwent the procedure with the gelsoft plus (so-631206p, 12mm x 6mm) for aaa on (b)(6) 2011 and there were no problems after the procedure.On (b)(6) 2023, blood leakage was observed from the bifurcation of the graft, causing the aneurysm to enlarge.Ivr treatment was considered, but the left branch of the graft was stenosed, and the patient underwent open surgery on (b)(6) 2024.The implanted graft was removed, and a hole was found at the bifurcation of the graft.Surgery was performed with a vascular graft (manufacturer and specifications unknown) and was successfully completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSOFT PLUS
Type of Device
GELSOFT PLUS BIFURCATE
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK   PA49RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, PA49R-R
UK   PA49RR
MDR Report Key18657164
MDR Text Key334724486
Report Number9612515-2024-00006
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K955230
Number of Events Reported1
Summary Report (Y/N)Y
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2013
Device Model NumberGELSOFT PLUS BIFURCATE
Device Catalogue Number631206P
Device Lot Number93461/1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/01/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-